ENDRA Life Sciences (NDRA) P/E (2017 - 2026)
ENDRA Life Sciences (NDRA) P/E from Jun 30, 2017 to Jun 2, 2026. The TTM ENDRA Life Sciences (NDRA) P/E is -0.68. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ENDRA Life Sciences (NDRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.68 | +23.17% |
| 2025 | -0.55 | +564.60% |
| 2024 | -0.08 | -99.48% |
| 2023 | -15.86 | -3.78% |
| 2022 | -16.48 | -68.24% |
| 2021 | -51.89 | +113.27% |
| 2020 | -24.33 | +23.63% |
| 2019 | -19.68 | +44.91% |
| 2018 | -13.58 | -91.64% |
| 2017 | -162.45 | N/A |
Comparison ENDRA Life Sciences (NDRA) P/E with competitors
ENDRA Life Sciences (NDRA) P/E is -0.68.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -214.72% |
| MBAI | CheckCap Ltd | 2.88 | -524.32% |
| FONR | Fonar Corp | 15.41 | -2368.67% |
| QGEN | Qiagen NV | 17.55 | -2682.86% |
| IQV | IQVIA Holdings Inc | 20.25 | -3080.61% |
| DGX | Quest Diagnostics Inc | 21.62 | -3282.25% |
| LH | Laboratory Corp Of America Holdings | 22.66 | -3435.69% |
| A | Agilent Technologies Inc | 25.45 | -3845.87% |
| MEDP | Medpace Holdings Inc | 26.32 | -3974.59% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | -4055.13% |
| MTD | Mettler-Toledo International Inc | 26.96 | -4068.38% |
| DHR | Danaher Corp | 33.26 | -4995.04% |
| ILMN | Illumina Inc | 34.97 | -5247.69% |
| ICLR | Icon Plc | 39.55 | -5920.75% |
| IDXX | Idexx Laboratories Inc | 40.14 | -6007.58% |
| VCYT | Veracyte Inc | 40.15 | -6010.40% |
| RVTY | Revvity Inc | 45.79 | -6840.16% |
| SHC | Sotera Health Company | 63.43 | -9436.32% |
| WAT | Waters Corp | 93.81 | -13907.81% |